Intuitive Surgical, Inc. Cash and Cash Equivalents, Period Increase (Decrease)
Intuitive Surgical, Inc. (ISRG) reported Cash and Cash Equivalents, Period Increase (Decrease) of $246.20 million for the 12-month period ending 2018-12-31, per its 10-K filed 2019-02-04.
Discontinued › Cash Flow › Change in Cash
us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease · last filed 2019-07-22
- Intuitive Surgical, Inc. cash and cash equivalents, period increase (decrease) for the quarter ending 2018-12-31 was -$113.90M.
- Intuitive Surgical, Inc. cash and cash equivalents, period increase (decrease) for the quarter ending 2018-09-30 was -$195.20M, a 209.36% decline year-over-year.
- Intuitive Surgical, Inc. cash and cash equivalents, period increase (decrease) for the quarter ending 2018-06-30 was $228.80M.
- Intuitive Surgical, Inc. cash and cash equivalents, period increase (decrease) for the quarter ending 2018-03-31 was $326.50M.
- Intuitive Surgical, Inc. cash and cash equivalents, period increase (decrease) for fiscal 2018 was $246.20M.
- Intuitive Surgical, Inc. cash and cash equivalents, period increase (decrease) for fiscal 2017 was -$388.40M, a 220.62% decline from fiscal 2016.
- Intuitive Surgical, Inc. cash and cash equivalents, period increase (decrease) for fiscal 2016 was $322.00M, a 181.71% increase from fiscal 2015.
- Intuitive Surgical, Inc. cash and cash equivalents, period increase (decrease) for fiscal 2015 was $114.30M.
| Period end | Cash and Cash Equivalents, Period Increase (Decrease) 3 month | Cash and Cash Equivalents, Period Increase (Decrease) 6 month | Cash and Cash Equivalents, Period Increase (Decrease) 6 month as first filed | Cash and Cash Equivalents, Period Increase (Decrease) 9 month | Cash and Cash Equivalents, Period Increase (Decrease) 9 month as first filed | Cash and Cash Equivalents, Period Increase (Decrease) 12 month | Cash and Cash Equivalents, Period Increase (Decrease) 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2018-12-31 | -$113.90M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-04 | -$309.10M derived: sum of 2 quarters · filed 2019-02-04 | -$80.30M derived: sum of 3 quarters · filed 2019-07-22 | $246.20M 10-K · filed 2019-02-04 | |||
| 2018-09-30 | -$195.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-22 | $33.60M derived: sum of 2 quarters · filed 2019-07-22 | $360.10M 10-Q · filed 2018-10-22 | $133.30M derived: sum of 4 quarters · filed 2019-07-22 | |||
| 2018-06-30 | $228.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-22 | $555.30M 10-Q · filed 2019-07-22 | $328.50M derived: sum of 3 quarters · filed 2019-07-22 | $507.00M derived: sum of 4 quarters · filed 2019-07-22 | |||
| 2018-03-31 | $326.50M 10-Q · filed 2019-04-19 | $99.70M derived: sum of 2 quarters · filed 2019-04-19 | $278.20M derived: sum of 3 quarters · filed 2019-04-19 | $266.10M derived: sum of 4 quarters · filed 2019-04-19 | |||
| 2017-12-31 | -$226.80M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-04 | -$48.30M derived: sum of 2 quarters · filed 2019-02-04 | -$60.40M derived: sum of 3 quarters · filed 2019-02-04 | -$388.40M 10-K · filed 2019-02-04 | |||
| 2017-09-30 | $178.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-22 | $166.40M derived: sum of 2 quarters · filed 2018-10-22 | -$161.60M 10-Q · filed 2018-10-22 | -$146.60M derived: sum of 4 quarters · filed 2019-02-04 | |||
| 2017-06-30 | -$12.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-20 | -$340.10M 10-Q · filed 2018-07-20 | -$325.10M derived: sum of 3 quarters · filed 2019-02-04 | -$497.00M derived: sum of 4 quarters · filed 2019-02-04 | |||
| 2017-03-31 | -$328.00M 10-Q · filed 2018-04-18 | -$313.00M derived: sum of 2 quarters · filed 2019-02-04 | -$484.90M derived: sum of 3 quarters · filed 2019-02-04 | -$271.90M derived: sum of 4 quarters · filed 2019-02-04 | |||
| 2016-12-31 | $15.00M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-04 | -$156.90M derived: sum of 2 quarters · filed 2019-02-04 | $56.10M derived: sum of 3 quarters · filed 2019-02-04 | $322.00M 10-K · filed 2019-02-04 | |||
| 2016-09-30 | -$171.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-20 | $41.10M derived: sum of 2 quarters · filed 2017-10-20 | $307.00M 10-Q · filed 2017-10-20 | $153.40M derived: sum of 4 quarters · filed 2018-02-02 | |||
| 2016-06-30 | $213.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-21 | $478.90M 10-Q · filed 2017-07-21 | $325.30M derived: sum of 3 quarters · filed 2018-02-02 | $278.10M derived: sum of 4 quarters · filed 2018-02-02 | |||
| 2016-03-31 | $265.90M 10-Q · filed 2017-04-19 | $112.30M derived: sum of 2 quarters · filed 2018-02-02 | $65.10M derived: sum of 3 quarters · filed 2018-02-02 | $279.40M derived: sum of 4 quarters · filed 2018-02-02 | |||
| 2015-12-31 | -$153.60M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-02 | -$200.80M derived: sum of 2 quarters · filed 2018-02-02 | $13.50M derived: sum of 3 quarters · filed 2018-02-02 | $114.30M 10-K · filed 2018-02-02 | |||
| 2015-09-30 | -$47.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-10-19 | $167.10M derived: sum of 2 quarters · filed 2016-10-19 | $267.90M 10-Q · filed 2016-10-19 | $375.20M derived: sum of 4 quarters · filed 2017-02-06 | |||
| 2015-06-30 | $214.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-07-20 | $315.10M 10-Q · filed 2016-07-20 | $422.40M derived: sum of 3 quarters · filed 2017-02-06 | $407.80M derived: sum of 4 quarters · filed 2017-02-06 | |||
| 2015-03-31 | $100.80M 10-Q · filed 2016-04-19 | $208.10M derived: sum of 2 quarters · filed 2017-02-06 | $193.50M derived: sum of 3 quarters · filed 2017-02-06 | -$112.90M derived: sum of 4 quarters · filed 2017-02-06 | |||
| 2014-12-31 | $107.30M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-06 | $92.70M derived: sum of 2 quarters · filed 2017-02-06 | -$213.70M derived: sum of 3 quarters · filed 2017-02-06 | -$181.80M 10-K · filed 2017-02-06 | |||
| 2014-09-30 | -$14.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-21 | -$321.00M derived: sum of 2 quarters · filed 2015-10-21 | -$289.10M 10-Q · filed 2015-10-21 | -$93.80M derived: sum of 4 quarters · filed 2016-02-02 | |||
| 2014-06-30 | -$306.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-22 | -$274.50M 10-Q · filed 2015-07-22 | -$79.20M derived: sum of 3 quarters · filed 2016-02-02 | $74.90M derived: sum of 4 quarters · filed 2016-02-02 | |||
| 2014-03-31 | $31.90M 10-Q · filed 2015-04-22 | $227.20M derived: sum of 2 quarters · filed 2016-02-02 | $381.30M derived: sum of 3 quarters · filed 2016-02-02 | $386.50M derived: sum of 4 quarters · filed 2016-02-02 | |||
| 2013-12-31 | $195.30M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-02 | $349.40M derived: sum of 2 quarters · filed 2016-02-02 | $354.60M derived: sum of 3 quarters · filed 2016-02-02 | $228.40M 10-K · filed 2016-02-02 | |||
| 2013-09-30 | $154.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-23 | $159.30M derived: sum of 2 quarters · filed 2014-10-23 | $33.10M 10-Q · filed 2014-10-23 | $190.60M derived: sum of 4 quarters · filed 2015-02-06 | |||
| 2013-06-30 | $5.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-24 | -$121.00M 10-Q · filed 2014-07-24 | $36.50M derived: sum of 3 quarters · filed 2015-02-06 | -$51.70M derived: sum of 4 quarters · filed 2015-02-06 | |||
| 2013-03-31 | -$126.20M 10-Q · filed 2014-04-25 | $31.30M derived: sum of 2 quarters · filed 2015-02-06 | -$56.90M derived: sum of 3 quarters · filed 2015-02-06 | $101.60M derived: sum of 4 quarters · filed 2015-02-06 | |||
| 2012-12-31 | $157.50M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-06 | $69.30M derived: sum of 2 quarters · filed 2015-02-06 | $227.80M derived: sum of 3 quarters · filed 2015-02-06 | $87.90M 10-K · filed 2015-02-06 | |||
| 2012-09-30 | -$88.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-18 | $70.30M derived: sum of 2 quarters · filed 2013-10-18 | -$69.60M 10-Q · filed 2013-10-18 | $98.00M derived: sum of 4 quarters · filed 2014-02-03 | |||
| 2012-06-30 | $158.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-07-22 | $18.60M 10-Q · filed 2013-07-22 | $186.20M derived: sum of 3 quarters · filed 2014-02-03 | $102.40M derived: sum of 4 quarters · filed 2014-02-03 | |||
| 2012-03-31 | -$139.90M 10-Q · filed 2013-04-19 | $27.70M derived: sum of 2 quarters · filed 2014-02-03 | -$56.10M derived: sum of 3 quarters · filed 2014-02-03 | -$123.90M derived: sum of 4 quarters · filed 2014-02-03 | |||
| 2011-12-31 | $167.60M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-03 | $83.80M derived: sum of 2 quarters · filed 2014-02-03 | $16.00M derived: sum of 3 quarters · filed 2014-02-03 | $186.00M 10-K · filed 2014-02-03 | |||
| 2011-09-30 | -$83.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-10-18 | -$151.60M derived: sum of 2 quarters · filed 2012-10-18 | $18.40M 10-Q · filed 2012-10-18 | -$83.80M derived: sum of 4 quarters · filed 2013-02-04 | |||
| 2011-06-30 | -$67.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-07-23 | $102.20M 10-Q · filed 2012-07-23 | $0.00 derived: sum of 3 quarters · filed 2013-02-04 | -$38.00M derived: sum of 4 quarters · filed 2013-02-04 | |||
| 2011-03-31 | $170.00M 10-Q · filed 2012-04-19 | $67.80M derived: sum of 2 quarters · filed 2013-02-04 | $29.80M derived: sum of 3 quarters · filed 2013-02-04 | $136.20M derived: sum of 4 quarters · filed 2013-02-04 | |||
| 2010-12-31 | -$102.20M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-04 | -$140.20M derived: sum of 2 quarters · filed 2013-02-04 | -$33.80M derived: sum of 3 quarters · filed 2013-02-04 | $58.40M 10-K · filed 2013-02-04 | |||
| 2010-09-30 | -$38.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-10-19 | $68.40M derived: sum of 2 quarters · filed 2011-10-19 | $160.60M 10-Q · filed 2011-10-19 | $175.90M derived: sum of 4 quarters · filed 2012-02-06 | |||
| 2010-06-30 | $106.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-07-20 | $198.60M 10-Q · filed 2011-07-20 | $213.90M derived: sum of 3 quarters · filed 2012-02-06 | $246.60M derived: sum of 4 quarters · filed 2012-02-06 | |||
| 2010-03-31 | $92.20M 10-Q · filed 2011-04-20 | $107.50M derived: sum of 2 quarters · filed 2012-02-06 | $140.20M derived: sum of 3 quarters · filed 2012-02-06 | $217.00M derived: sum of 4 quarters · filed 2012-02-06 | |||
| 2009-12-31 | $15.30M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-06 | $48.00M derived: sum of 2 quarters · filed 2012-02-06 | $124.80M derived: sum of 3 quarters · filed 2012-02-06 | $26.80M 10-K · filed 2012-02-06 | $26.81M 10-K · filed 2010-01-29 | ||
| 2009-09-30 | $32.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2010-10-20 | $109.50M derived: sum of 2 quarters · filed 2010-10-20 | $11.50M 10-Q · filed 2010-10-20 | $11.47M 10-Q · filed 2009-10-21 | -$21.49M derived: sum of 4 quarters · filed 2011-02-01 | ||
| 2009-06-30 | $76.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2010-07-23 | -$21.20M 10-Q · filed 2010-07-23 | -$21.20M 10-Q · filed 2009-07-23 | -$54.19M derived: sum of 3 quarters · filed 2011-02-01 | -$49.60M derived: sum of 4 quarters · filed 2011-02-01 | ||
| 2009-03-31 | -$98.00M 10-Q · filed 2010-04-20 | -$130.99M derived: sum of 2 quarters · filed 2011-02-01 | -$126.40M derived: sum of 3 quarters · filed 2011-02-01 | ||||
| 2008-12-31 | -$32.99M derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-01 | -$28.40M derived: sum of 2 quarters · filed 2011-02-01 | $71.80M 10-K · filed 2011-02-01 | $71.80M 10-K · filed 2010-01-29 | |||
| 2008-09-30 | $4.59M derived: 10-Q 9 month − 10-Q 6 month · filed 2009-10-21 | $104.79M 10-Q · filed 2009-10-21 | |||||
| 2008-06-30 | $100.20M 10-Q · filed 2009-07-23 | ||||||
| 2007-12-31 | $88.44M 10-K · filed 2010-01-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Edwards Lifesciences Corp (EW) | United States | $49.409B | 51.96 |
| STERIS plc (STE) | Ireland | $20.343B | 25.49 |
| ZIMMER BIOMET HOLDINGS, INC. (ZBH) | United States | $17.103B | 20.66 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |